Skip to main content

Animations

MJFF Publications

2931 - 2940 of 8399 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • OPEN
    Title: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-26066-5
    Citation Count: 164
  • RESTRICTED
    Title: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease
    Journal Name: Seminars in Thrombosis and Hemostasis
    Publisher: Georg Thieme Verlag KG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1055/s-0041-1733960
    Best OA location URL:
    Citation Count: 5
  • RESTRICTED
    Title: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulation
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/science.abi7852
    Best OA location URL:
    Citation Count: 122
  • RESTRICTED
    Title: Visual dysfunction is associated with cognitive impairment in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005
    Best OA location URL:
    Citation Count: 11
  • OPEN
    Title: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0257372
    Citation Count: 35
  • OPEN
    Title: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.148649
    Citation Count: 7
  • RESTRICTED
    Title: New Insights from a Two-Country Study Comparing Escalation Strategies for MS Drugs
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Then and Now: 20 Years of Monumental Strides in Movement Disorders
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28805
    Best OA location URL:
    Citation Count: 27
  • OPEN
    Title: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab374
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.